Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Riley, S.
Right arrow Articles by Hendry, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Riley, S.
Right arrow Articles by Hendry, B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrology Dialysis Transplantation, Vol 12, Issue 9 1921-1927, Copyright © 1997 by Oxford University Press


ORIGINAL ARTICLES

Characterization of human erythrocyte choline transport in chronic renal failure

S Riley, N Talbot, M Ahmed, K Jouhl and B Hendry
Renal Group, Department of Medicine, King's College School of Medicine and Dentistry, Bessemer Road, London SE5 9PJ, UK; Corresponding author

Background. Membrane transport of choline cations is elevated in renal failure in erythrocytes and cerebral tissue but the origins and clinical importance of this are unknown. Methods. The membrane transport changes have been characterized using erythrocytes from patients on maintenance haemodialysis (HD), patients on continuous ambulatory peritoneal dialysis (CAPD), and control subjects. Data were obtained from cells depleted of intracellular choline to create zero-trans (ZT) conditions for choline influx. [14C]-choline influx measurements provided a kinetic description of choline flux as the sum of a saturable transport system (defined by Vmax and Km) and an apparent diffusion pathway. Inhibition of choline transport by hemicholinium-3 (HC-3), quinine and N-ethylmaleimide (NEM) has been studied. Actions of three cationic polyamine putative uraemic toxins (putrescine, spermidine, spermine) were tested in control erythrocytes. Results. Mean (SEM) Vmax (ZT) was increased in HD at 45.0 (3.0) &mgr;mol/l cells/h and in CAPD at 46.6 (2.5) &mgr;mol/l cells/h compared to controls (30.0 (2.0) &mgr;mol/l cells/h). Mean Km (ZT) was not significantly altered in HD or CAPD (HD: 6.1 (1.6) &mgr;M; CAPD: 5.5 (0.7) &mgr;M; control: 5.1 (0.9) &mgr;M). The sensitivity of choline transport to the inhibitors tested was not altered in HD. 1.0 mM quinine, 2.0 mM NEM and 1.0 mM HC-3 caused 75-90% inhibition of transport in both HD and controls. For inhibition of ZT influx of 25 &mgr;M choline the mean IC50 of quinine was 90 (9) &mgr;M in HD and 101 (13) &mgr;M in controls (n.s.). the ZT influx of 200 &mgr;M choline was not altered by any of the polyamines at concentrations up to 1.0 mM. Conclusions. Membrane choline transport in CRF remains protein-mediated and exhibits normal substrate and inhibitor affinities; high values of Vmax seem to occur through increased surface expression of an active normal choline transporter. Increases in plasma polyamines cannot explain the choline transport changes in CRF. Keywords: choline; chronic renal failure; erythrocyte; membrane transport; polyamines; uraemia
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
J. Kuncova, J. Sviglerova, W. Kummer, D. Rajdl, M. Chottova-Dvorakova, Z. Tonar, L. Nalos, and M. Stengl
Parasympathetic regulation of heart rate in rats after 5/6 nephrectomy is impaired despite functionally intact cardiac vagal innervation
Nephrol. Dial. Transplant., August 1, 2009; 24(8): 2362 - 2370.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
V. Michel, Z. Yuan, S. Ramsubir, and M. Bakovic
Choline Transport for Phospholipid Synthesis.
Experimental Biology and Medicine, May 1, 2006; 231(5): 490 - 504.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.